ASF Standards · Ambulatory Clinic · Standard 11

Standard 11 — Oncology & Infusion Therapy

4 criteria · 4 non-negotiable · 0 core · Version 3.0

Criteria in this standard

11.1 — Cytotoxic Drug Handling Follows a Verified Safe-Handling Standard
11.2 — Chemotherapy Dose Is Verified by Independent Two-Person Check
11.3 — Extravasation Is Recognised and Managed Immediately
11.4 — Infusion Reaction and Anaphylaxis Response Is Rehearsed, Not Theoretical

11.1

Cytotoxic Drug Handling Follows a Verified Safe-Handling Standard

Non-Negotiable

Preparation, administration, and disposal of cytotoxic and other hazardous drugs follows a defined, verified safe-handling standard — appropriate personal protective equipment, engineering controls, and disposal procedures — not informal practice that varies by individual staff member.

In plain terms: Chemotherapy is prepared, given, and disposed of following a verified safe-handling standard — closed systems, PPE, spill kits — protecting staff as well as patients.

Facility category	Crisis	Transition	Small	Standard
Applicability	N/A	Full	Full	Full

Why this matters

Cytotoxic drugs damage the people who handle them: nurses and pharmacists exposed to chemotherapy over years have higher rates of miscarriage, cancer, and chromosomal damage. Exposure happens through skin contact, inhalation of aerosols during preparation, and contaminated surfaces. Safe handling means a defined standard — USP 800, ISOPP, or national equivalent — with engineering controls (biological safety cabinet or closed-system transfer devices), correct PPE (chemotherapy gloves, gown, eye protection), a spill kit in every area, and staff trained and competency-assessed. A clinic preparing chemotherapy on an open bench is poisoning its staff slowly.

What good looks like

PPE is used consistently and correctly at every handling stage.
Required engineering controls are documented and in place.
A defined, compliant hazardous waste disposal pathway is followed.

Common failure modes

PPE use is inconsistent or limited to administration only.
Standard pharmacy equipment is used without required hazardous drug controls.
Hazardous waste is disposed of as general medical waste.

Worked example

In practice

An oncology day unit administering chemotherapy from six chairs.

BeforeChemotherapy was reconstituted in a side room with a standard laminar flow hood (which protects the product, not the operator). Nurses wore single latex gloves. No spill kit existed. Waste went in yellow bags. Surface contamination had never been tested.

ActionThe unit adopted ISOPP standards. A closed-system transfer device was introduced for all preparations. Chemotherapy-rated nitrile gloves (double), gowns, and eye protection became mandatory. Spill kits were placed in the preparation room and at the chairs. Cytotoxic waste was segregated into purple-lidded containers. All staff completed a safe-handling course with competency sign-off. Annual surface wipe testing was scheduled.

AfterThe Monitor observed a preparation using the CSTD with correct PPE, found spill kits in place, reviewed training and competency records for all staff, and reviewed the first wipe test results (below detection limit). Verified.

If you are starting from zero — do this first

Where is chemotherapy prepared? Is the cabinet designed to protect the operator or the product?
Check gloves: are they chemotherapy-rated? Double?
Find your spill kit. If none, order one for each area today.
Adopt a recognised standard and train every handler to it.

The most common mistake: Using a laminar flow hood for chemotherapy — it blows the drug toward the operator.

Self-assessment questions

1. Is appropriate personal protective equipment — including chemotherapy-rated gloves and gowns — used consistently for every stage of handling? — Consistent use at every stage, not only during administration.
Evidence: PPE protocol and observation record

2. Are hazardous drugs prepared and stored using the required engineering controls, not standard pharmacy equipment? — Specific, required controls, not general pharmacy practice assumed to be sufficient.
Evidence: Engineering control documentation

3. Is hazardous waste disposed of through a defined, compliant pathway, not general medical waste? — A specific, separate disposal pathway matched to the actual risk.
Evidence: Waste disposal record

Common reasons for a PARTIAL answer

PPE is used correctly during administration but less consistently during preparation. — Every handling stage carries real exposure risk, not administration alone.
Engineering controls exist but staff weren't specifically trained on their correct use. — Correct equipment without correct training doesn't provide the intended protection.
Waste disposal follows the correct pathway for most hazardous drugs but not all categories on the hazardous list.

Implementation plan

When	What
Week 1	Review current handling practice against required PPE, engineering controls, and disposal standards.
Week 2	Address any gaps in PPE use or engineering controls.
Week 3	Establish or verify a compliant hazardous waste disposal pathway.
Ongoing	Train staff periodically and audit handling practice.

How the Monitor verifies this

Method	What	Detail
OBSERVE	PPE and handling observation	Observes actual handling practice across preparation, administration, and disposal stages.
DOCUMENT	Engineering control review	Reviews documentation of required engineering controls for hazardous drug preparation and storage.
DOCUMENT	Waste disposal pathway review	Reviews the defined hazardous waste disposal pathway and compliance records.

Supervisor tips

Observe preparation and disposal, not only administration. — Attention often concentrates on administration, leaving earlier and later stages less consistently observed.
Ask to see the actual hazardous waste disposal pathway and its documentation. — A specific, verifiable pathway is the real evidence of compliant disposal.

Evidence base

[57] Established hazardous drug handling standards, recognized in various forms across many countries' pharmacy and occupational safety guidance, require defined personal protective equipment, engineering controls, and procedures for the receipt, storage, compounding, administration, and disposal of hazardous drugs.

Train your team: AMB-11 · Oncology & Infusion on GMJ Academy →

This course teaches practical implementation of this standard. Free to enroll. ASF certificate on completion.

11.2

Chemotherapy Dose Is Verified by Independent Two-Person Check

Non-Negotiable

Every chemotherapy dose, drug, route, and infusion rate is independently verified by two qualified individuals before administration, each forming their own judgement separately — not a single check followed by a second signature.

In plain terms: Every chemotherapy dose is checked by two qualified people independently — each calculating on their own, then comparing — before it is given.

Facility category	Crisis	Transition	Small	Standard
Applicability	N/A	Full	Full	Full

Why this matters

A tenfold chemotherapy overdose is fatal. A dose calculated from last month's weight, or an outdated body surface area, or a protocol for the wrong cancer, kills or harms. The independent double-check is the last barrier: two people, each separately verifying the patient, the drug, the dose calculation from current parameters, the route, the rate, and the cumulative dose against the protocol. Then they compare. If either has any discrepancy, the dose is not given until it is resolved. One person checking and the other initialling is not independent.

What good looks like

Every dose undergoes genuine, independent two-person verification.
Each verifier forms their own separate judgement.
Verification covers drug, dose, route, and infusion rate together.

Common failure modes

Verification happens for some doses but not consistently for all.
The second check simply confirms the first person's conclusion.
Verification covers dose alone, missing route or infusion rate.

Worked example

In practice

An oncology day unit where a pharmacist prepared doses and a nurse administered them.

BeforeThe pharmacist calculated and prepared. The nurse checked the label against the prescription and gave it. Neither independently recalculated. A patient received a dose based on a weight recorded three months earlier, before 12 kg of weight loss; the overdose caused a prolonged admission.

ActionAn independent double-check was implemented: pharmacist and nurse each separately verify patient identity, current weight and height (measured that day), BSA, protocol, drug, dose calculation, cumulative dose, route, and rate — on separate forms — then compare. Any discrepancy stops administration. Both sign. Weight is measured at every cycle.

AfterThe Monitor observed two administrations with genuinely independent calculations and comparison. Reviewed 20 records with double signatures and same-day weights. Verified.

If you are starting from zero — do this first

Watch a chemotherapy check. Does the second person calculate, or just look?
Require current-day weight and height for every dose.
Create two identical check sheets — one per checker — and compare before giving.
Write the rule: any discrepancy stops the dose.

The most common mistake: Using the weight from the first cycle for all subsequent cycles — chemotherapy patients lose weight.

Self-assessment questions

1. Does every chemotherapy dose undergo independent verification by two qualified individuals before administration? — Two people, every dose, without exception for perceived routine cases.
Evidence: Independent double-check record

2. Does each person form their own separate judgement, not simply confirm the first person's check? — Genuine independence, not sequential confirmation of the same conclusion.
Evidence: N/A — tested directly

3. Does verification specifically cover drug, dose, route, and infusion rate together, not dose alone? — All four elements, since an error in any one carries real risk.
Evidence: Verification checklist content

Common reasons for a PARTIAL answer

Independent verification is strong for new regimens but becomes routine and less rigorous for familiar ones. — Familiarity can quietly erode the genuine independence the check depends on.
Verification happens together, side by side, rather than separately before comparing. — Checking together risks one person's read of the order influencing the other's, undermining genuine independence.
Infusion rate verification is inconsistent compared to drug and dose verification.

Implementation plan

When	What
Week 1	Review current verification practice for genuine independence between checkers.
Week 2	Retrain staff on separate, independent verification before comparing conclusions.
Week 3	Confirm the verification checklist covers drug, dose, route, and infusion rate together.
Ongoing	Audit verification records and observe practice periodically.

How the Monitor verifies this

Method	What	Detail
OBSERVE	Independent check observation	Observes an actual double-check for genuine independence between the two verifiers.
DOCUMENT	Verification record review	Reviews records confirming two-person verification for a sample of recent administrations.
ASK	Verification content interview	Asks staff what specifically gets verified during the double-check.

Supervisor tips

Observe an actual double-check, watching specifically for separate, independent review. — Genuine independence is visible in practice in a way records alone cannot confirm.
Ask two different verifiers separately what they checked. — Consistent, specific answers from both reveal genuine independent verification.

Evidence base

[58] Neuss MN, Gilmore TR, Belderson KM, Billett AL, Conti-Kalchik T, Harvey BE, et al. 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology. J Oncol Pract. 2016;12(12):1262-1271 — mandates independent verification by two qualified individuals of chemotherapy drug, dose, route, and infusion rate prior to administration.

Train your team: AMB-11 · Oncology & Infusion on GMJ Academy →

This course teaches practical implementation of this standard. Free to enroll. ASF certificate on completion.

11.3

Extravasation Is Recognised and Managed Immediately

Non-Negotiable

Staff administering vesicant or irritant chemotherapy agents are specifically trained to recognise early signs of extravasation, with a defined, immediate management protocol and appropriate antidotes genuinely available on-site.

In plain terms: Staff giving vesicant chemotherapy can spot leakage into tissue immediately, and the antidotes and protocol are at the chair — because minutes matter.

Facility category	Crisis	Transition	Small	Standard
Applicability	N/A	Full	Full	Full

Why this matters

Vesicants — anthracyclines, vinca alkaloids, taxanes — cause tissue death when they leak from the vein. Left unrecognised for an hour, the result is a wound that needs surgery, months to heal, and can end limb function. The signs — pain, swelling, loss of blood return, slowed drip — appear early and are easy to attribute to 'a bit of discomfort.' Management is drug-specific: dexrazoxane for anthracyclines within six hours; hyaluronidase and warm compresses for vincas; specific antidotes stored, in date, at the point of care. Staff must be trained to stop, aspirate, and act — not to wait and see.

What good looks like

Staff are specifically trained on extravasation recognition for the actual agents used.
A defined, immediate management protocol exists.
Appropriate antidotes are genuinely on-site and in date.

Common failure modes

Training is generic, not specific to the agents actually administered.
No defined protocol exists beyond general awareness that extravasation can occur.
Antidotes aren't on-site or are expired.

Worked example

In practice

An oncology day unit giving vesicant chemotherapy daily.

BeforeNo extravasation kit existed. Dexrazoxane was not stocked. When a patient complained of pain during doxorubicin, the nurse slowed the infusion and continued. The extravasation was recognised the next day; the patient required surgical debridement.

ActionAn extravasation kit was assembled and placed at the nurses' station with drug-specific antidotes, cold and warm packs, and a laminated protocol. Dexrazoxane was stocked with the pharmacy. All chemotherapy nurses completed extravasation training including a simulation. The rule: any pain, swelling, or lost blood return during a vesicant → stop, aspirate, do not remove the cannula, call the doctor, start the protocol. Every event is logged and reviewed.

AfterThe Monitor found the kit stocked and in date, the protocol posted, and training records complete. Asked a nurse the first four actions; she listed them. Verified.

If you are starting from zero — do this first

Ask: where is your extravasation kit? What antidotes are in it? Are they in date?
Stock drug-specific antidotes for every vesicant you give.
Post the protocol at every chair.
Train and drill every chemotherapy nurse.

The most common mistake: Slowing the infusion when the patient reports pain instead of stopping it — the drug is still going in.

Self-assessment questions

1. Are staff specifically trained to recognise early signs of extravasation for the agents actually used here? — Specific to the actual agents administered, not generic infusion complication awareness.
Evidence: Extravasation recognition training record

2. Is there a defined, immediate management protocol for suspected extravasation? — A specific, known protocol, not improvisation in the moment.
Evidence: Extravasation management protocol

3. Are appropriate antidotes for the specific vesicant agents used genuinely available on-site? — Immediately available and in date, matched to the actual agents in use.
Evidence: On-site antidote stock record

Common reasons for a PARTIAL answer

Recognition training happened at hiring but hasn't been refreshed as new agents were introduced. — Training needs to stay current with the actual agents in use, not reflect an earlier point in time.
A protocol exists but doesn't specify agent-specific management steps. — Different vesicant agents may require different specific management approaches.
Antidote stock exists but expiry dates weren't recently verified.

Implementation plan

When	What
Week 1	Review current extravasation training against the specific agents administered.
Week 2	Update or establish an agent-specific management protocol.
Week 3	Confirm on-site antidote stock and expiry dates for all vesicant agents used.
Ongoing	Refresh training whenever new agents are introduced.

How the Monitor verifies this

Method	What	Detail
DOCUMENT	Recognition training review	Reviews training records for extravasation recognition specific to agents actually used.
DOCUMENT	Management protocol review	Reviews the defined immediate management protocol for completeness.
OBSERVE	Antidote stock check	Physically confirms appropriate antidotes are on-site, matched to agents used, and in date.

Supervisor tips

Ask about a specific agent used here, not extravasation in general. — Specificity reveals whether training genuinely reflects current practice.
Physically check antidote stock and expiry dates. — Physical verification is the only real evidence of genuine on-site availability.

Evidence base

[59] Extravasation recognition and immediate management protocols, including agent-specific antidote availability, are established as a distinct and essential component of safe chemotherapy administration, separate from general infusion site monitoring.

Train your team: AMB-11 · Oncology & Infusion on GMJ Academy →

This course teaches practical implementation of this standard. Free to enroll. ASF certificate on completion.

11.4

Infusion Reaction and Anaphylaxis Response Is Rehearsed, Not Theoretical

Non-Negotiable

Staff are trained and drilled — not only briefed — on recognising and responding to infusion reactions and anaphylaxis, with emergency medications and equipment genuinely available at the point of infusion, verified through a real, practiced response, not a written plan alone.

In plain terms: Staff have practised — not just read about — recognising and treating infusion reactions and anaphylaxis, and the emergency drugs and equipment are at the chair.

Facility category	Crisis	Transition	Small	Standard
Applicability	N/A	Full	Full	Full

Why this matters

Infusion reactions to monoclonal antibodies, platinum agents, and taxanes range from flushing to fatal anaphylaxis within minutes. The first-line response — stop the infusion, give adrenaline for anaphylaxis, oxygen, fluids, antihistamine, steroid — must be immediate and reflexive. Staff who have been briefed but never drilled hesitate; staff who have drilled act. Emergency drugs must be at the chair, not in a cupboard down the corridor. A unit that has never run a simulation does not know how its staff will respond.

What good looks like

Staff have genuinely rehearsed the response, with dated drill records.
Emergency medications and equipment are immediately available at the point of infusion.
Staff can describe their specific, assigned role in a response.

Common failure modes

Only written protocol review has occurred, with no actual drill.
Emergency equipment requires retrieval from another location.
Staff are aware a protocol exists but can't describe their specific role.

Worked example

In practice

An oncology day unit administering monoclonal antibodies.

BeforeStaff had attended a lecture on infusion reactions. Adrenaline was in the emergency drawer at the nurses' station. No drill had ever been run. When a patient developed anaphylaxis to rituximab, the nurse called for help and waited; adrenaline was given after seven minutes.

ActionAn anaphylaxis kit was placed at each infusion bay: adrenaline, antihistamine, hydrocortisone, salbutamol, oxygen, and the protocol. A quarterly simulation drill was introduced, alternating scenarios, with a debrief. Every nurse is competency-assessed annually on the response sequence. Pre-medication protocols per drug were standardised.

AfterThe Monitor found kits at every bay, reviewed three drill records with debrief actions, and observed a mock reaction drill in which adrenaline was 'given' within 90 seconds. Verified.

If you are starting from zero — do this first

Time how long it takes to get adrenaline from where it is kept to the furthest infusion chair.
Put a kit at every bay.
Run a simulation drill this month and debrief it.
Make drills quarterly.

The most common mistake: Keeping emergency drugs in one central location in a unit where reactions happen at the chair.

Self-assessment questions

1. Have staff actually rehearsed an infusion reaction and anaphylaxis response, not only reviewed a written protocol? — A genuine drill, not a policy document read once.
Evidence: Drill record, date and participants

2. Are emergency medications and equipment genuinely available at the point of infusion, not in a separate location requiring retrieval? — Immediately at hand, not requiring travel to another room during an emergency.
Evidence: Emergency equipment location and stock record

3. Do all staff present during infusions know their specific role in a reaction response, not just that a protocol exists? — Specific, assigned roles, not general awareness.
Evidence: N/A — tested directly

Common reasons for a PARTIAL answer

A drill was conducted once but hasn't been repeated since. — Rehearsed response capability fades over time without periodic repetition, particularly given staff turnover.
Emergency equipment is nearby but not genuinely at every point where infusions actually happen. — A reaction can occur at any infusion chair, and equipment needs to be immediately reachable from all of them.
Clinical staff know their role clearly but support staff present during infusions are less certain.

Implementation plan

When	What
Week 1	Assess current response readiness against genuine rehearsed practice, not policy review alone.
Week 2	Conduct an actual reaction response drill with all relevant staff.
Week 3	Verify emergency equipment is genuinely accessible from every infusion point.
Ongoing	Repeat drills periodically, particularly after staff changes.

How the Monitor verifies this

Method	What	Detail
DOCUMENT	Drill record review	Reviews records of actual rehearsed drills, not only protocol review sessions.
OBSERVE	Emergency equipment location check	Confirms emergency medications and equipment are genuinely at the point of infusion.
ASK	Role assignment interview	Asks staff present during infusions to describe their specific role in a reaction response.

Supervisor tips

Ask for the date of the last actual drill, not the date the protocol was written. — A specific, recent drill date is the real evidence of rehearsed readiness.
Ask a support staff member, not just a nurse, about their role in a response. — This reveals whether readiness genuinely extends to everyone present, not only clinical staff.

Evidence base

[60] Infusion reaction and anaphylaxis response protocols, including rehearsed drills rather than written policy alone, are identified as essential to safe ambulatory infusion practice given the narrow time window in which effective intervention determines patient outcome.

Train your team: AMB-11 · Oncology & Infusion on GMJ Academy →

This course teaches practical implementation of this standard. Free to enroll. ASF certificate on completion.

← Ambulatory Clinic Standards — all standards
Self-assess against these criteria →
← Standard 10 — Longevity & IV Therapy
Standard 12 — Dialysis & Renal Replacement Therapy →